Historique de carrière de Anette Sundstedt
Anciens postes connus de Anette Sundstedt
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ALLIGATOR BIOSCIENCE AB | Directeur/Membre du Conseil | 05/07/2023 | 07/05/2024 |
CanImGuide Therapeutics AB
 CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Corporate Officer/Principal | 01/04/2020 | 01/03/2021 |
| ACTIVE BIOTECH AB | Directeur/Membre du Conseil | 01/01/2001 | 01/01/2016 |
| IDOGEN AB (PUBL) | Directeur Technique/Scientifique/R&D | - | - |
Formation de Anette Sundstedt
| University of Lund | Doctorate Degree |
Statistiques
Internationale
| Suède | 6 |
Opérationnelle
| Director/Board Member | 2 |
| Doctorate Degree | 1 |
| Graduate Degree | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ACTIVE BIOTECH AB | Health Technology |
| IDOGEN AB (PUBL) | Health Technology |
| ALLIGATOR BIOSCIENCE AB | Health Technology |
| Entreprise privées | 1 |
|---|---|
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Health Technology |
- Bourse
- Insiders
- Anette Sundstedt
- Expérience
